Impact of Lower Urinary Tract Symptoms on Quality of Life Using Functional Assessment Cancer Therapy Scale

Urology

Volumn 69, Issue 2, 2007, Pages 285-288

  Batista Miranda, Jose E ^a   Molinuevo, Beatriz ^b   Pardo, Yolanda ^b  

^a Urodynamics Unit   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BENIGN PROSTATIC HYPERPLASIA IMPACT INDEX; BLADDER EMPTYING; DISEASE SEVERITY; FUNCTIONAL ASSESSMENT CANCER THERAPY SCALE; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; NOCTURIA; OUTPATIENT; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SCORING SYSTEM; WELLBEING;

ADAPTATION, PSYCHOLOGICAL; AGE FACTORS; AGED; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; NOCTURIA; PATIENT PARTICIPATION; PROBABILITY; PROGNOSIS; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; URINARY RETENTION; URINATION DISORDERS; URODYNAMICS;

EID: 33847215525     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.09.054     Document Type: Article

References (21)

1. Girman C.J., Jacobsen S.J., Tsukamoto T., et al. Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology 51 (1998) 428-436
2. Donovan J.L., Kay H.E., Peters T.J., et al. Using the ICSQOL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS -"BPH" study. Br J Urol 80 (1997) 712-721
3. MacDonagh R.P., Cliff A.M., Speakman M.J., et al. The use of generic measures of health-related quality of life in the assessment of outcome from transurethral resection of the prostate. Br J Urol 79 (1997) 401-408
4. Boyle P., Robertson C., Mazzetta C., et al. The relationship between lower urinary tract symptoms and health status: the UREPIK study. Br J Urol 92 (2003) 575-580
5. Cella D.F., Tulsky D.S., Gray G., et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11 (1993) 570-579
6. Cella D.F., Hernandez L., Bonomi A.E., et al. Spanish language translation and initial validation of the functional assessment of cancer therapy quality-of-life instrument. Med Care 36 (1998) 1407-1418
7. Overcash J., Extermann M., Parr J., et al. Validity and reliability of the FACT-G scale for use in the older person with cancer. Am J Clin Urol 24 (2001) 591-596
8. Dutta S.C., Chang S.C., Coffey C.S., et al. Health related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder. J Urol 168 (2002) 164-167
9. Cookson M.S., Dutta S.C., Chang S.S., et al. Health related quality of life in patients treated with radical cystectomy and urinary diversion for urothelial carcinoma of the bladder: development and validation of a new disease specific questionnaire. J Urol 170 (2003) 1926-1930
10. Batista-Miranda J.E., Sevilla-Cecilia C., Torrubia R., et al. Quality of life in prostate cancer patients and controls: psychometric validation of the FACTP-4 in Spanish, and relation to urinary symptoms. Arch Esp Urol 56 (2003) 447-454
11. Batista-Miranda J.E., Regalado R., Chechile G., et al. IPSS questionnaire in patients and controls: psychometric validation. Act Urol Esp 19 (1995) 93-101
12. th ed. (2001), Plymbridge Distributors, Plymouth, United Kingdom 519-534
13. Barry M.J., Fowler F.J., O'Leary M.P., et al. The American Urological Association Symptom Index for benign prostatic hyperplasia. J Urol 148 (1992) 1549-1557
14. Esper P., Mo F., Chodak G., et al. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology 50 (1997) 920-928
15. Dapueto J.J., Servente L., Francolino C., et al. Determinants of quality of life in patients with cancer: a South American study. Cancer Cytopathol 103 (2005) 1072-1081
16. Barry M.J., Fowler F.J., O'Leary M.P., et al., Measurement Committee of the American Urological Association. Measuring disease-specific health status in men with benign prostatic hyperplasia. Med Care 33 (1995) 145-155
17. Badía X., García-Losa M., Dal-Re R., et al. Validation of a harmonized Spanish version of the IPSS: evidence of equivalence with the original American scale. Urology 52 (1998) 614-620
18. Yoshimura K., Arai Y., Ichioka K., et al. Symptom-specific quality of life in patients with benign prostatic hyperplasia. Int J Urol 9 (2002) 485-490
19. Araki I., Zakoji H., Komuro M., et al. Lower urinary tract symptoms in men and women without underlying disease causing micturition disorder: a cross sectional study assessing the natural history of bladder function. J Urol 170 (2003) 1901-1904
20. Haltbakk J., Hanestad B.R., and Hunsakar S. How important are mens' lower urinary tract symptoms (LUTS) and their impact on the quality of life (QOL)?. Qual Life Res 14 (2005) 1733-1741
21. Cooley M.E., McCorckle R., Knafi G.J., et al. Comparison of health related quality of life questionnaires in ambulatory oncology. Qual Life Res 14 (2005) 1239-1249